Research
Network
- Research Institutions
  Our academic collaborators’ seminal contributions push the field forward
- Directory
  Our constellation of renowned thinkers and partners
- Strategic Partnerships
  The right collaborators across pharma, biotech and nonprofit
- Early Career Researcher Awards
  The next generation of scientific leaders in cancer immunotherapy
News
- News Menu
  - The Latest
    Stories & Announcements
  - News Coverage
    PICI in the News
  - Podcast
    From Bench to Fireside
About
- Mission & Vision
  Develop breakthrough immune therapies to turn all cancers into curable diseases faster
- Leadership & Team
  The driving force behind PICI’s research and operations
- Careers
  Join us. Change lives.
Press
Donate

University of California, San Francisco

UCSF researchers and physicians work across disciplines to develop cutting-edge cancer immunotherapies

The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments.

Kole Roybal, PhD | Director
Julia Carnevale, MD | Co-Director

All Investigators

University of California, San Francisco

Related